Alvotech Shares Are Trading Higher Today After the Company Signed an Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in the US.
Alvotech Shares Are Trading Higher Today After the Company Signed an Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in the US.
Alvotech的股價今天上漲，此前該公司簽署了擴大在美國獲得Humira生物仿製藥Adalimumab-RYVK的准入的協議。
Alvotech Shares Are Trading Higher Today After the Company Signed an Agreement to Expand Access to Humira Biosimilar Adalimumab-ryvk in the US.
Alvotech的股價今天上漲，此前該公司簽署了擴大在美國獲得Humira生物仿製藥Adalimumab-RYVK的准入的協議。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。